Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-07-05
2011-07-05
Gussow, Anne M. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S300000, C424S130100, C514S002600, C435S007100
Reexamination Certificate
active
07973135
ABSTRACT:
The invention provides molecules that target cancer-specific transcription complexes (CSTC), compositions and kits comprising CSTC-targeting molecules, and methods of using CSTC-targeting molecules for the treatment) detection and monitoring of cancer.
REFERENCES:
patent: 6248520 (2001-06-01), Roeder et al.
patent: 6268173 (2001-07-01), Chambon et al.
patent: 6380373 (2002-04-01), O'Malley
patent: 6586185 (2003-07-01), Wolf et al.
patent: 6861508 (2005-03-01), Chambon et al.
patent: 6965850 (2005-11-01), Baxter et al.
patent: 2003/0228607 (2003-12-01), Wagner et al.
patent: 2004/0031072 (2004-02-01), La Rosa et al.
patent: 2004/0214272 (2004-10-01), La Rosa et al.
patent: 2004/0219575 (2004-11-01), Neuman et al.
patent: 2005/0202440 (2005-09-01), Fletterick et al.
patent: 2003/000270 (2003-01-01), None
patent: WO 99/60014 (1999-11-01), None
patent: WO 2000/001820 (2000-01-01), None
patent: WO 02/02488 (2002-01-01), None
patent: WO 02/40716 (2002-05-01), None
patent: WO 02/095652 (2002-11-01), None
patent: WO 03/033515 (2003-04-01), None
Skolnick and Fetrow. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology, 2000. vol. 18, pp. 34-39.
Burgess, Shaheen, Ravera, Jaye, Donohue, and Winkles. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor binding activities by site directed mutagenesis of a single lysine residue. Journal of Cell Biology, 1990. vol. 111, pp. 2129-2138.
Lazar, Watanabe, Dalton, and Sporn. Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities. Molecular and Cellular Biology, 1988. vol. 8, pp. 1247-1252.
Onate, S.A., et al., “The Steroid Receptor Coactivator-1 Contains Multiple . . . Receptors”, J of Biological Chemistry, vol. 273, No. 20, May 15, 1998, pp. 12101-12108.
Ding, X.F. et al., “Nuclear Receptor-Bonding Sites of Coactivators . . . Specificities”, Mol. Endocrinol., vol. 12(2):302-313, Feb. 1998.
Flajollet, S. et al., “Distinct Roles of the Steroid Receptor Coactivator 1 . . . Differentiation”, J. of Biological Chemistry, 281(29):20338-20348, Jul. 2006.
Giangrande, P. et al., “The Opposing Transcriptional Activities of the Two Isoforms . . . Binding”, Molecular & Cellular Biology, 20(9):3102-3115, May 2000.
Wu, J. et al., Repression of p65 Transciptional Activation . . . Receptor, Molecular Endocrinology, 18(1):53-62, Jan 2004. (Abstract & result of sequence search).
Scarabel, L, Molecular Basis and Genetic Characterisation of Evolved . . . Rhoeas, Plant Science, 166:703-709, 2004, (Abstract & result of sequence search).
European Patent Office Search Report dated Dec. 23, 2009 from corresponding EP Patent Application No. 07812873.3.
Kazantseva Anna
Liik Anzelika
Canady Karen S.
canady + lortz LLP
Gussow Anne M.
Oncotx, Inc.
LandOfFree
Compositions and methods for targeting cancer-specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for targeting cancer-specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for targeting cancer-specific... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2673809